Prospective Case Collection Study for New Mammography Technologies
NCT ID: NCT05199701
Last Updated: 2025-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
7500 participants
INTERVENTIONAL
2021-12-10
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram
NCT00535678
Test of Digital Breast Tomosynthesis vs. Regular Mammography in Detecting Breast Cancer in Women Undergoing Diagnostic Mammography
NCT00535327
Test of Digital Breast Tomosynthesis vs. Common Mammography to Detect Breast Cancer for Women Undergoing Breast Biopsy
NCT00535184
Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
NCT01669148
Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device
NCT06636539
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Investigational Mammogram Exam
Mammography
All subjects who are indicated for a screening or diagnostic mammogram or breast biopsy will undergo an investigational exam in a new mammography device.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mammography
All subjects who are indicated for a screening or diagnostic mammogram or breast biopsy will undergo an investigational exam in a new mammography device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is at least 35 years old.
* Subject is indicated for a screening or diagnostic mammogram or breast biopsy.
Exclusion Criteria
* Subject has breast implants, cardiac pacemakers, nipple piercings, or IV ports in the mammography field of view.
* Subject previously participated in the study.
35 Years
100 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hologic, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Banner MD Anderson Cancer Center
Gilbert, Arizona, United States
Southwest Medical Imaging
Gilbert, Arizona, United States
Scottsdale Medical Imaging LTD
Scottsdale, Arizona, United States
Miami Breast Institute
Coral Gables, Florida, United States
Diagnostic Centers of America Palm Beach Gardens
Palm Beach Gardens, Florida, United States
Diagnostic Centers of America West Palm Beach
West Palm Beach, Florida, United States
Baptist Health
Louisville, Kentucky, United States
Progressive Radiology
Bel Air, Maryland, United States
Corewell Health
Grand Rapids, Michigan, United States
Elizabeth Wendy Breast Care
Rochester, New York, United States
Solis Mammography Greensboro
Greensboro, North Carolina, United States
Solis Mammography Columbus
Columbus, Ohio, United States
Solis Mammography Burleson
Burleson, Texas, United States
Washington Radiology
Arlington, Virginia, United States
Washington Radiology
Sterling, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Geena Thomas
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.